Johnson’s Vaccine Single Shot Highly Effective - Fda

The US Food and Drug Administration (FDA) declared on Wednesday that a single-shot coronavirus vaccine made by Johnson & Johnson proved to be safe and effective and completely prevented hospitalizations and deaths in a large clinical trial.

The Johnson & Johnson vaccine was more than 85 percent effective at preventing severe illness, including in a region dominated by a concerning variant, but only 66 percent protective overall when moderate cases were included, the FDA said.

The review sets the stage for a third coronavirus vaccine to be authorized as soon as this weekend, a point of hope in the middle of a pandemic that has killed more than a half-million people in the United States.

 

SOURCE : TIMES KUWAIT

Comments Post Comment

Leave a Comment

Submit